A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas | MicrobiomeTrials← Back to trialsNCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2019-09-18Est. Completion: 2030-02-27
Enrollment target: 300 participants Locations- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- University of Chicago, Chicago, Illinois, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- University of Maryland Medical Ctr, Baltimore, Maryland, United States
- Massachusetts General Hospital (MGH), Boston, Massachusetts, United States
- Dana Farber Cancer Institute (HARVARD), Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- NYU Langone Medical Center, New York, New York, United States
- Weill Medical College of Cornell University, New York, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
- Montefiore Einstein Center for Cancer Care (MECCC), The Bronx, New York, United States
Other microbiome trials you might be interested in
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oropharyngeal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma
University of Cincinnati Cancer Institute, Cincinnati, Ohio, United StatesAbramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United StatesSouth Texas Accelerated Research Therapeutics (START) - San Antonio, San Antonio, Texas, United StatesSouth Texas Accelerated Research Therapeutics (START) - Midwest Location, San Antonio, Texas, United StatesUniversity of Virginia Health System (UVAHS), Charlottesville, Virginia, United StatesSwedish Cancer Institute, Seattle, Washington, United StatesFred Hutchinson Cancer Center, Seattle, Washington, United StatesCHU Bordeaux Hopital Saint Andre, Bordeaux, FranceCLCC Institut Bergonie, Bordeaux, FranceCentre Oscar Lambret, Lille, FranceCentre Leon Berard, Lyon, FranceCHU Nantes Hopital Hotel Dieu, Nantes, FranceCHU Nantes Hopital Hotel Dieu, Nantes, FranceCHU Nantes Hopital Nord Laennec, Saint-Herblain, FranceInstitut Cancerologie de Strasbourg, Strasbourg, FranceCLCC Institut Gustave Roussy, Villejuif, FranceAzienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi, Bologna, ItalyFondazione IRCCS Istituto Nazionale Dei Tumori, Milan, ItalyNational Cancer Institute, IRCCS, Milan, ItalyEuropean Institute of Oncology (IEO), IRCCS ( Department of Urogenital and Head-and-Neck Medical Oncology), Milan, ItalyEuropean Institute of Oncology (IEO), IRCCS, Milan, ItalyHumanitas San Pio X, Milan, ItalyIRCCS Policlinico Universitario Fondazione Agostino Gemelli, Roma, ItalyIRCCS Istituto Clinico Humanitas - Research Hospital, Rozzano, ItalyUniwersyteckie Centrum Kliniczne GUMed, Gdansk, PolandNarodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Gliwice, PolandPratia MCM, Krakow, PolandInstitute of Polish Mother Health Centre - ICZMP, Lodz, PolandCentrum Medyczne Pratia - Poznan, Poznan, PolandUniversity Teaching Hospital, Poznan, PolandNovartis Investigative Site, Daegu, South KoreaNational Cancer Center, Goyang-si Gyeonggi-do, South KoreaGachon University Gil Medical Center, Incheon, South KoreaSeoul National University Hospital, Seoul, South KoreaYonsei Univ Health System YUCM, Seoul, South KoreaAsan Medical Center, Seoul, South KoreaGangnam Severance Hospital, Seoul, South KoreaThe Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, South KoreaHospital Vall d Hebron, Barcelona, SpainHospital Clinic of Barcelona, Barcelona, SpainCatalan Institute of Oncology, Barcelona, SpainHospital Universitari de Girona Doctor Josep Trueta, Girona, SpainUniversity Hospital Ramon y Cajal, Madrid, SpainUniversity Hospital Clinical San Carlos, Department of Medical Oncology, Madrid, SpainUniversity Hospital Foundation Jimenez Diaz, Madrid, SpainHospital Universitario 12 de Octubre, Madrid, SpainPuerta de Hierro Majadahonda University Hospital, Majadahonda, SpainHospital Universitario Son Espases, Palma, SpainClinica Universidad de Navarra, Pamplona, SpainClinica Universidad de Navarra, Pamplona, SpainHospital Universitario Quirónsalud Madrid, Pozuelo de Alarcón, SpainParc Taulí Hospital Universitari, Sabadell, SpainHematology Department - Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, SpainSantiago Clinic Hospital CHUS, Santiago de Compostela, SpainHospital Virgen del Rocio, Seville, SpainInstituto Valenciano de Oncologia, Valencia, SpainLa Fe University and Polytechnic Hospital, Valencia, SpainRoyal United Hospital Bath NHS Trust, Bath, United KingdomLeicester General Hospital, Leicester, United KingdomImperial College Healthcare NHS Trust, London, United KingdomThe Christie NHS Foundation Trust, Manchester, United KingdomChurchill Hospital, Oxford, United KingdomSouthampton General Hospital, Southampton, United KingdomThe Royal Marsden NHS Foundation Trust - Royal Marsden Hospital (RMH), Sutton, United KingdomThe Royal Marsden NHS Foundation Trust - Royal Marsden Hospital (RMH), Sutton, United KingdomMusgrove Park Hospital, Taunton, United KingdomMetastatic Melanoma
Metastatic Oral Cavity Squamous Cell Carcinoma
Metastatic Oropharyngeal Squamous Cell Carcinoma
Recurrent Melanoma
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Lip and Oral Cavity Cancer AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Hypopharyngeal Carcinoma AJCC v8
Stage IV Laryngeal Cancer AJCC v8
Stage IV Lip and Oral Cavity Cancer AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Unresectable Melanoma
This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in tr…
Phoenix, United StatesEst. completion Jan 1, 2027
Advanced Solid TumorsMalignant Neoplasm
Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has s…
Birmingham, United StatesEst. completion Oct 25, 2028
Solid Tumors
This is a prospective, single-center, open-label clinical study comparing the imaging performance of INR202 PET/CT versu…
Multiple LocationsEst. completion Jul 2028